Home LiteratureArticle Details
PMID: 12108865 Published · ppublish English Journal Article

Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia.

The European respiratory journal ·Vol. 19 ·No. 6 ·2002-06-00 ·Pages 1114-8

Riha RL, Duhig EE, Clarke BE, Steele RH, Slaughter RE, Zimmerman PV

Abstract

This is the first Australian study to examine survival and clinical characteristics in biopsy-proven idiopathic interstitial pneumonia. A cohort of 70 patients from a single institution between January 1990 and December 1999 was reviewed. All patients were Caucasian, 23 (33%) female. Mean age+/-SD at diagnosis was 60+/-12 yrs for males and 54+/-14 yrs for females. A total 24% of patients had never smoked. The histopathological diagnoses were usual interstitial pneumonia (UIP) (n=59), nonspecific interstitial pneumonia (NSIP) (n=7), desquamative interstitial pneumonia (n=3) and acute interstitial pneumonia (n=11). Clinical and functional characteristics of the two main histological subgroups of UIP and NSIP showed significantly older patients in the UIP group and a significantly lower mean forced expiratory volume in one second (FEV1) in the NSIP group. Median survival for UIP was 78 months compared with 178 months for NSIP. No survival difference between treated and untreated patients with UIP was found. Multivariate analysis revealed smoking alone to be predictive of poorer survival. This study demonstrates the best median survival for usual interstitial pneumonia of available series and confirms a survival difference between usual interstitial pneumonia and nonspecific interstitial pneumonia. Furthermore, the reported results may have implications for treatment timing using conventional protocols currently recommended.

MeSH Terms
Adolescent Adult Aged Aged, 80 and over Biopsy Cyclophosphamide/therapeutic use Cyclosporine/therapeutic use Female Humans Immunosuppressive Agents/therapeutic use Lung Diseases, Interstitial/drug therapy,mortality,pathology Male Middle Aged Multivariate Analysis Steroids/therapeutic use Survival Analysis
Chemicals
Immunosuppressive Agents Steroids Cyclosporine Cyclophosphamide
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Riha R L
Thoracic and Radiology Dept, The Prince Charles Hospital, Brisbane, Australia. R.L.Riha@ed.ac.uk
Duhig E E
Clarke B E
Steele R H
Slaughter R E
Zimmerman P V
Article Info
Journal
The European respiratory journal
Abbr.
Eur Respir J
ISSN
0903-1936
Published
2002-06-00
Pages
1114-8
Language
English
Region
England
NLM ID
8803460
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com